Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Challenges in safely deprescribing common anticholinergic drugs

Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson's disease.

11 Feb 2022

Open-label placebo shows promise as therapy for disorders of gut-brain interaction in children

Pain-predominant disorders of gut-brain interaction (DGBIs) in children -; such as functional abdominal pain (FAP) and irritable bowel syndrome (IBS)-; can lead to disabling symptoms, poor quality of life and high use of health care resources.

31 Jan 2022

NYU Langone Health continues to expand its services on Long Island

NYU Langone Health continues to build its breadth and depth of services on Long Island, enhancing local access to high-quality care with the recent addition of a new location, new providers, and several specialties.

31 Jan 2022

Drugs that block mineralocorticoid receptor may help protect bone cells during aging

Drugs we take like prednisone can weaken our bones and so can aging, and scientists working to prevent both have some of the first evidence that the best target may not be the logical one.

5 Jan 2022

Are our bowel habits written in our DNA?

In this interview, News-Medical talks to Dr. Mauro D’Amato about how there could be clues about the regularity of bowel movements within our genes.

24 Dec 2021

Specific diets have less effect on IBS symptoms than expected

Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms.

16 Dec 2021

Study reveals distinct gut microbial 'signatures' highly responsive to dietary therapy for IBS

People who respond well to the recommended dietary therapy of restricting intake of fermentable carbs for irritable bowel syndrome, or IBS for short, have an abundance of particular types of bacteria in their gut, reveals research published online in the journal Gut.

23 Nov 2021

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

A recent study evaluates the immune responses elicited by COVID-19 vaccines in infliximab- or vedolizumab-treated IBD patients.

15 Nov 2021

Microbiome discovery may help improve treatment for patients with gastrointestinal diseases

University of Calgary researchers probing the gut -; "the inner tube of life" -; have for the first time discovered specific factors in its workings that in the future may help improve treatment for patients facing gut damage or gastrointestinal disease.

12 Nov 2021

Research reveals how gut macrophages respond to prior infection by shielding enteric neurons

A simple stomach bug could do a lot of damage. There are 100 million neurons scattered along the gastrointestinal tract-;directly in the line of fire-;that can be stamped out by gut infections, potentially leading to long-term GI disease.

30 Oct 2021

MSU researchers make surprising discovery about the human gut's enteric nervous system

Researchers at Michigan State University have made a surprising discovery about the human gut's enteric nervous system that itself is filled with surprising facts. For starters, there's the fact that this "second brain" exists at all.

2 Oct 2021

Microbiome startups promise to improve your gut health, but is the science solid?

After Russell Jordan sent a stool sample through the mail to the microbiome company Viome, his idea of what he should eat shifted. The gym owner in Sacramento, California, had always consumed large quantities of leafy greens.

25 Aug 2021

Glycyrrhizic acid as a drug candidate for COVID-19

A new study presents the benefits of licorice, an age-old herbal remedy, to treat COVID-19 at all stages.

24 Aug 2021

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.

29 Jul 2021

Acidic environment enhances production of butyric acid from apple pectin by fecal microbiota

Researchers from Tallinn University of Technology, Grete Raba, Signe Adamberg, and Kaarel Adamberg showed that an acidic environment enhances the production of butyric acid from apple pectin by fecal bacterial consortia - microbiota.

29 Jun 2021

Anti-coronavirus molecules from microbes could be key to new treatments

Microbes in the gut that produce beneficial compounds could hold the key to treating coronavirus symptoms.

21 Jun 2021

Irritable bowel syndrome is linked to bacterial biofilms in the gut

One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.

21 Jun 2021

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

Researchers from Yonsei University in South Korea have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.

21 Jun 2021

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.

From Bedfont® Scientific Ltd 10 Jun 2021

Are women more likely to develop long COVID?

Researchers found different groups of symptoms persisting after coronavirus disease 2019 (COVID-19), with fatigue and higher IL-6 levels common in women. About 75% of the patients they treated were women, indicating a link between sex hormones and immune response.

8 Jun 2021

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Challenges in safely deprescribing common anticholinergic drugs

Open-label placebo shows promise as therapy for disorders of gut-brain interaction in children

NYU Langone Health continues to expand its services on Long Island

Drugs that block mineralocorticoid receptor may help protect bone cells during aging

Are our bowel habits written in our DNA?

Specific diets have less effect on IBS symptoms than expected

Study reveals distinct gut microbial 'signatures' highly responsive to dietary therapy for IBS

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

Microbiome discovery may help improve treatment for patients with gastrointestinal diseases

Research reveals how gut macrophages respond to prior infection by shielding enteric neurons

MSU researchers make surprising discovery about the human gut's enteric nervous system

Microbiome startups promise to improve your gut health, but is the science solid?

Glycyrrhizic acid as a drug candidate for COVID-19

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Acidic environment enhances production of butyric acid from apple pectin by fecal microbiota

Anti-coronavirus molecules from microbes could be key to new treatments

Irritable bowel syndrome is linked to bacterial biofilms in the gut

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely

Are women more likely to develop long COVID?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in